Skip to main content
BHST
NASDAQ Life Sciences

BioHarvest Sciences Appoints Co-Founder Dr. Zaki Rakib as CEO; Former CEO Ilan Sobel Joins Board

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$4.27
Mkt Cap
$96.792M
52W Low
$4.1
52W High
$12.8
Market data snapshot near publication time

Summary

BioHarvest Sciences announced a strategic leadership change, appointing co-founder Dr. Zaki Rakib as CEO to integrate key operations, while former CEO Ilan Sobel joins the Board to focus on D2C growth.


Key Events

  • New CEO Appointment

    Dr. Zaki Rakib, Co-Founder and Executive Chairman, has been appointed Chief Executive Officer, consolidating leadership of R&D, Manufacturing, and Operations in the CDMO division.

  • Former CEO Transitions to Board

    Ilan Sobel, who served as CEO since 2020, has transitioned from his executive role and has been appointed to the Company's Board of Directors, where he will focus on advancing the D2C business.

  • Strategic Focus

    The leadership transition is designed to sharpen execution of the company's "two-lens strategy" across its direct-to-consumer (D2C) business and its Contract Development and Manufacturing Organization (CDMO) business.

  • New CEO's Experience

    Dr. Rakib brings over 35 years of executive leadership experience, including scaling Terayon Communication Systems to $380 million in annual revenue and a $7 billion market capitalization as a Nasdaq-listed company.


Analysis

This strategic leadership transition aims to accelerate BioHarvest Sciences' "two-lens" growth strategy, focusing on its direct-to-consumer (D2C) and Contract Development and Manufacturing Organization (CDMO) businesses. Dr. Rakib, a co-founder with a strong track record, will consolidate R&D, Manufacturing, and Operations under the CDMO, while former CEO Ilan Sobel will leverage his expertise on the Board to advance the D2C segment. This move, occurring while the stock trades near its 52-week low, signals a proactive effort to optimize leadership and drive future growth.

At the time of this filing, BHST was trading at $4.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $96.8M. The 52-week trading range was $4.10 to $12.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BHST - Latest Insights

BHST
May 18, 2026, 7:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.20 info
Change: -$0.900 (-22%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 3:59 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $3.20 info
Change: -$1.05 (-25%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 1:06 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.06
Real-time Price: $3.20 info
Change: -$0.860 (-21%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 10:27 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.06
Real-time Price: $3.20 info
Change: -$0.860 (-21%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 7:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $4.01
Real-time Price: $3.20 info
Change: -$0.805 (-20%) info
Market Cap: $72.537M info
BHST
May 13, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $3.71
Real-time Price: $3.20 info
Change: -$0.510 (-14%) info
Market Cap: $72.537M info
BHST
May 12, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $3.20 info
Change: -$0.810 (-20%) info
Market Cap: $72.537M info
BHST
Apr 29, 2026, 2:09 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.27
Real-time Price: $3.20 info
Change: -$1.07 (-25%) info
Market Cap: $72.537M info
BHST
Mar 31, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $3.20 info
Change: -$1.10 (-26%) info
Market Cap: $72.537M info
BHST
Mar 26, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.36
Real-time Price: $3.20 info
Change: -$1.16 (-27%) info
Market Cap: $72.537M info